Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods.
BOZZANI, FM; MCCREESH, N; Diaconu, K; GOVENDER, I; WHITE, RG; Kielmann, K; GRANT, AD; VASSALL, A;
2023
BMJ Global Health, (2023).8 2 10.1136/bmjgh-2022-010306.
Journey of the tuberculosis patients in India from onset of symptom till one-year post-treatment. Complete dataset.
Chatterjee, S; Das, P; Shikhule, A; Munje, R; VASSALL, A;
2023
, PLOS Global Public Health (2023).
Journey of the tuberculosis patients in India from onset of symptom till one-year post-treatment.
Chatterjee, S; Das, P; Shikhule, A; Munje, R; VASSALL, A;
2023
PLOS global public health, (2023).3 2 10.1371/journal.pgph.0001564.
Impact of Reversion of Mycobacterium tuberculosis Immunoreactivity Tests on the Estimated Annual Risk of Tuberculosis Infection.
SCHWALB, A; Emery, JC; Dale, KD; HORTON, KC; Ugarte-Gil, CA; HOUBEN, RM G J;
2023
American journal of epidemiology, (2023).192 12 10.1093/aje/kwad028.
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities.
Fehr, J; Gunda, R; Siedner, MJ; Hanekom, W; Ndung U, T; GRANT, A; Lippert, C; Wong, EB;
2023
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, (2023).27 2 10.5588/ijtld.22.0437.
Genome-wide host-pathogen analyses reveal genetic interaction points in tuberculosis disease.
PHELAN, J; Gomez-Gonzalez, PJ; Andreu, N; Omae, Y; Toyo-Oka, L; Yanai, H; Miyahara, R; Nedsuwan, S; De Sessions, PF; CAMPINO, S; Sallah, N; Parkhill, J; Smittipat, N; Palittapongarnpim, P; Mushiroda, T; Kubo, M; Tokunaga, K; Mahasirimongkol, S; HIBBERD, ML; CLARK, TG;
2023
Nature communications, (2023).14 1 10.1038/s41467-023-36282-w.
Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: a systematic review and meta-analysis.
Gray, AT; Macpherson, L; Carlin, F; Sossen, B; RICHARDS, A; Kik, S; Houben, R; MacPherson, P; Quartagno, M; Rogozińska, E; Esmail, H;
2023
medRxiv (2023). 10.1101/2023.01.27.23285085.
Contribution of remote M.tuberculosis infection to tuberculosis disease: A 30-year population study.
GLYNN, JR; KHAN, P; Mzembe, T; Sichali, L; FINE, PE M; CRAMPIN, AC; HOUBEN, RM G J;
2023
PloS one, (2023).18 1 10.1371/journal.pone.0278136.
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Portnoy, A; CLARK, RA; Quaife, M; WEERASURIYA, CK; Mukandavire, C; Bakker, R; Deol, AK; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, RG; Menzies, NA;
2023
PLOS Medicine, (2023).20 1 10.1371/journal.pmed.1004155.
Second-line drug resistance markers as proxy indicators of time to sputum culture conversion among second-line drug resistant tuberculosis patients tested in Uganda: A cross-sectional study.
Mujuni, D; Ssengooba, W; Ibanda, I; Kabugo, JS; Kasemire, DL; Nampewo, E; Nsawotebba, A; PHELAN, JE; Tugumisirize, D; Orena, B; Byabajungu, H; Ntenkaire, N; Nadunga, D; Tumwine, J; Musisi, K; Joloba, M; Kim, S; Kokas, I; Mukani, WO; Kungu, J; Afayoa, M;
2023
F1000Research, (2023).12, 10.12688/f1000research.129524.1.